Characterisation of portal hypertension models by microspheres in anaesthetised rats: A comparison of liver flow

Pharmacology and Therapeutics

Volumn 90, Issue 1, 2001, Pages 35-43

  Van de Casteele, Marc ^a,b   Sägesser, Hans ^a   Zimmermann, Heinz ^a   Reichen, Jürg ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Liver flow; Microspheres; Portal hypertension; Rat

Indexed keywords

CARBON TETRACHLORIDE; MICROSPHERE; PENTOBARBITAL;

ASCITES; BILE DUCT LIGATION; CLINICAL FEATURE; DISEASE MODEL; HEMODYNAMICS; LIVER CIRRHOSIS; LIVER PERFUSION; LIVER RESECTION; LIVER SINUSOID; LIVER WEIGHT; NONHUMAN; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; REVIEW; VEIN LIGATION;

ANIMALS; ASCITES; BILE DUCTS; BLOOD FLOW VELOCITY; CARBON TETRACHLORIDE; DISEASE MODELS, ANIMAL; HEMODYNAMIC PROCESSES; HYPERTENSION, PORTAL; LIVER; LIVER CIRRHOSIS; MICROSPHERES; PENTOBARBITAL; PORTAL VEIN; RATS;

EID: 0034929805     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0163-7258(01)00123-1     Document Type: Review

References (71)

1. Hepatic venous pressure measurement: An old test as a new prognostic marker in cirrhosis
2. Quantity error in blood flow measurements with radioactive microspheres
3. Forward and backward flow mechanisms of portal hypertension. Relative contributions in the rat model of portal vein stenosis
4. Chronic portal hypertension: Effects on gastrointestinal blood flow distribution
5. Reduction of the increased portal vascular resistance of the isolated perfused cirrhotic rat liver by vasodilators
6. Changes in splanchnic blood flow in portal hypertensive rats
7. Pharmacokinetic-hemodynamic interactions in cirrhosis
8. Portal-systemic shunting and the hemodynamic effects of nitroglycerin in the rat
9. Distribution of portal blood flow in the liver of the rat: A microsphere study
10. Complications of cirrhosis. I. Portal hypertension
11. Continuous monitoring of portal vein and hepatic artery hemodynamics in unrestrained rats
12. Should measurements of hemodynamics in portal hypertension be dynamic?
13. Superior portosystemic collateral circulation estimated by azygos blood flow in patients with cirrhosis. Lack of correlation with oesophageal varices and gastrointestinal bleeding. Effect of propranolol
14. Splenorenal shunt blood flow by transit-time ultrasound as an index of collateral circulation in portal hypertensive rats
15. Measurement of portal-systemic shunting in the rat by using gamma-labeled microspheres
16. Liver circulation in the development of portal hypertension
17. Regulation of sinusoidal perfusion: In vivo methodology and control by endothelins
18. Cardiac output by dye dilution in the conscious rat
19. Influence of anesthesia, postanesthetic state, and restraint on superior mesenteric arterial flow in normal rats
20. Effects of ketamine, halothane, enflurane, and isoflurane on systemic and splanchnic hemodynamics in normovolemic and hypovolemic cirrhotic rats
21. Liver microvascular architecture: An insight into the pathophysiology of portal hypertension
22. 4 cirrhosis in rats: Irreversible histological changes and differentiated functional impairment
23. Effects of continued NO inhibition on portal hypertensive syndrome after portal vein stenosis in rat
24. Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment
25. The evolution of changes in quantitative liver function tests in a rat model of biliary cirrhosis: Correlation with morphometric measurement of hepatocyte mass
26. Hemodynamic characteristics of the intrahepatic portal vascular bed over an extended flow range: A study in the isolated perfused rat liver
27. Splanchnic hemodynamics in portal hypertensive rats: Measurements with gamma labeled microspheres
28. The porto-systemic collateral pattern in the rat; an angiographic and anatomical study of the portal vein
29. Eliminating metabolic abnormalities of portocaval shunting by restoring normal liver blood flow
30. Effects of L-arginine on the systemic, mesenteric and hepatic circulation in patients with cirrhosis
31. Drug administration to liver patients: Aspects of liver pathophysiology
32. Portal hypertension in primary biliary cirrhosis
33. Reduction of transmural oesophageal variceal pressure by metoclopramide
34. Effects of intra-atrial injection of colored microspheres on systemic hemodynamics and regional blood flow in rats
35. Model for the study of portal-systemic collateral vascular resistance in the conscious rat
36. Prolonged bile duct obstruction: A new experimental model for cirrhosis in the rat
37. Expiratory measurement of maximal aminopyrine demethylation in vivo: Effect of phenobarbital, partial hepatectomy, portocaval shunt and bile duct ligation in the rat
38. Animal models of portal hypertension
39. Pharmacological treatment of portal hypertension: Present and future
40. Comparison of the circulation between fed and fasted normal and portal hypertensive rats
41. Hemodynamic characterization of chronic bile duct-ligated rats: Effect of pentobarbital sodium
42. Reference sample method for cardiac output and regional blood flow determinations in the rat
43. Lipoic acid prevents development of the hyperdynamic circulation in anesthetized rats with biliary cirrhosis
44. Effect of vasodilators on hepatic microcirculation in cirrhosis: A study in the isolated perfused rat liver
45. Application of HPLC to counting of colored microspheres in determination of regional blood flow
46. Morphological mechanisms for regulating blood flow through hepatic sinusoids
47. An improved method for producing cirrhosis of the liver in rats by simultaneous administration of carbon tetrachloride and phenobarbitone
48. 4-induced liver cirrhosis
49. The effect of long-term treatment with spironolactone on variceal pressure in patients with portal hypertension without ascites
50. Normalization of nitric oxide production corrects arterial vasodilation and hyperdynamic circulation in cirrhotic rats
51. Measurement of collateral circulation blood flow in anesthetized portal hypertensive rats
52. Role of portal and splenic vein shunts and impaired hepatic extraction in the elevated serum bile acids in liver cirrhosis
53. 4-treated rats
54. Modulation of the hyperdynamic circulation of cirrhotic rats by nitric oxide inhibition
55. Chronic blockade of endothelin receptors in cirrhotic rats: Hepatic and hemodynamic effects
56. Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension
57. Aminopyrine N-demethylation by rats with liver cirrhosis. Evidence for the intact cell hypothesis. A morphometric-functional study
58. Liver blood flow: I. Intrinsic and nervous control of liver blood flow
59. Peripheral arterial vasodilation: Determinant of functional spectrum of cirrhosis
60. The hepatic circulation in health and disease: Report of a single-topic symposium
61. Clinical usefulness of evaluation of portal circulation by per rectal scintigraphy with technetium-99m pertechnate
62. Hemodynamic characterization of conscious and ketamine-anesthetized bile duct-ligated rats
63. Hemodynamic disturbances in the rat as a function of the number of microspheres injected
64. Evaluation of portal-systemic shunting in rats from mesenteric and splenic beds
65. A rat model of esophageal varices
66. Intraportal administration of glyceryl trinitrate or nitroprusside exerts more systemic than intrahepatic effects in anaesthetised cirrhotic rats
67. 4 treated cirrhotic rats
68. Spleno-renal shunt blood flow is an accurate index of collateral circulation in different models of portal hypertension and after pharmacological changes in rats
69. Increased blood flow through the portal system in cirrhotic rats
70. Reversibility of secondary biliary fibrosis by biliodigestive anastomosis in the rat
71. Effect of development on the functional and histological changes induced by bile-duct ligation in the rat